Effect of intestinal microbes on the efficacy of immune checkpoint inhibitors in the treatment of non-small cell lung cancer
At present, with the deepening of the understanding of intestinal microecology, the regulation of intestinal microecology will also be included in the entire management of immunotherapy. Studies have suggested that the use of probiotics, prebiotics, Biostime or antibiotics in combination with tumor immunotherapy can rebalance the intestinal microecology. Therefore, it is urgent to further study the effect and mechanism of intestinal microbiome on immunotherapy efficacy.